Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
NPJ Parkinson'S Disease|December 13, 2025
Optogenetic-induced α-synuclein accumulation reveals early synaptic dysfunction in experimental models of Parkinson's diseaseRaquel Rodriguez-Aller, Beatriz Romero-Quineche, Marc Morissette, et al.
Neuropharmacology|July 7, 2009
Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptidesMohamed Khalil Tamim, Pershia Samadi, Marc Morissette, et al.
Synapse (New York, N.Y.)|June 2, 2006
Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: effect on adenosine A2A receptorsMarc Morissette, Mehdi Dridi, Frédéric Calon, et al.
Journal of Molecular Neuroscience : MN|August 16, 2008
Implication of NMDA receptors in the antidyskinetic activity of cabergoline, CI-1041, and Ro 61-8048 in MPTP monkeys with levodopa-induced dyskinesiasBazoumana Ouattara, Samah Belkhir, Marc Morissette, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 30, 2005
Prevention of levodopa-induced dyskinesias by a selective NR1A/2B N-methyl-D-aspartate receptor antagonist in parkinsonian monkeys: implication of preproenkephalinMarc Morissette, Mehdi Dridi, Frédéric Calon, et al.
Brain Research Bulletin|July 5, 2022
Differential contribution of estrogen receptors to the intestinal therapeutic effects of 17β-estradiol in a murine model of Parkinson's diseaseAndrée-Anne Poirier, Mélissa Côté, Mélanie Bourque, et al.
Neurobiology of Disease|July 29, 2009
Nur77 mRNA levels and L-Dopa-induced dyskinesias in MPTP monkeys treated with docosahexaenoic acidSouha Mahmoudi, Pershia Samadi, François Gilbert, et al.
Brain Research|August 24, 2017
Plasmalogen precursor mitigates striatal dopamine loss in MPTP miceEdith Miville-Godbout, Mélanie Bourque, Marc Morissette, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 21, 2002
Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatmentFrédéric Calon, Marc Morissette, Othman Ghribi, et al.
Neuropharmacology|November 16, 2007
Basal ganglia group II metabotropic glutamate receptors specific binding in non-human primate model of L-Dopa-induced dyskinesiasPershia Samadi, Laurent Grégoire, Marc Morissette, et al.
Pageof 8